NCT05072444View on ClinicalTrials.gov

Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

November 23, 2021

Study Completion Date

November 23, 2021

Conditions
Bacterial Infections
Interventions
DRUG

QPX7728

beta lactamase inhibitor

DRUG

QPX2014

antibiotic

Trial Locations (1)

90630

Altasciences, Cypress

All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Qpex Biopharma, Inc.

INDUSTRY

NCT05072444 - Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter